Robert D. Hardie - Net Worth and Insider Trading
Robert D. Hardie Net Worth
The estimated net worth of Robert D. Hardie is at least $22 Million dollars as of 2024-11-13. Robert D. Hardie is the 10% Owner of Acumen Pharmaceuticals Inc and owns about 8,277,142 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $22 Million. Details can be seen in Robert D. Hardie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert D. Hardie has not made any transactions after 2021-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert D. Hardie
Robert D. Hardie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert D. Hardie owns 2 companies in total, including PLx Pharma Winddown Corp (PLXPQ) , and Acumen Pharmaceuticals Inc (ABOS) .
Click here to see the complete history of Robert D. Hardie’s form 4 insider trades.
Insider Ownership Summary of Robert D. Hardie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLXPQ | PLx Pharma Winddown Corp | 2020-11-18 | 10 percent owner |
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 10 percent owner |
Robert D. Hardie Latest Holdings Summary
Robert D. Hardie currently owns a total of 1 stock. Robert D. Hardie owns 8,277,142 shares of Acumen Pharmaceuticals Inc (ABOS) as of July 6, 2021, with a value of $22 Million.
Latest Holdings of Robert D. Hardie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 8,277,142 | 2.68 | 22,182,741 |
Holding Weightings of Robert D. Hardie
Robert D. Hardie Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert D. Hardie has made a total of 2 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the acquisition of 750,000 shares on July 6, 2021, which cost Robert D. Hardie around $12 Million.
Insider Trading History of Robert D. Hardie
- 1
Robert D. Hardie Trading Performance
GuruFocus tracks the stock performance after each of Robert D. Hardie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert D. Hardie is -26.49%. GuruFocus also compares Robert D. Hardie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert D. Hardie within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert D. Hardie's insider trading performs compared to the benchmark.
Performance of Robert D. Hardie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.69 | | | | | |
| Relative Return to S&P 500(%) | -27.83 | | | | | |
Robert D. Hardie Ownership Network
Ownership Network List of Robert D. Hardie
Ownership Network Relation of Robert D. Hardie
Robert D. Hardie Owned Company Details
What does PLx Pharma Winddown Corp do?
Who are the key executives at PLx Pharma Winddown Corp?
Robert D. Hardie is the 10 percent owner of PLx Pharma Winddown Corp. Other key executives at PLx Pharma Winddown Corp include director & Chief Executive Officer Natasha Giordano , Chief Financial Officer Rita M O'connor , and director & Executive Chairman Michael J Valentino .
PLx Pharma Winddown Corp (PLXPQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PLx Pharma Winddown Corp (PLXPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PLx Pharma Winddown Corp (PLXPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PLx Pharma Winddown Corp (PLXPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
PLx Pharma Winddown Corp Insider Transactions
Robert D. Hardie Mailing Address
Above is the net worth, insider trading, and ownership report for Robert D. Hardie. You might contact Robert D. Hardie via mailing address: 210 Ridge Mcintire Road, Suite 350, Charlottesville Va 22903.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
